Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for smarca4 protein, human (compound)
Most Correlated Studies
- Adrenal carcinoma SW-13 cells with SUZ12 and BRM knockdown
- Adrenal carcinoma SW 13 cells response to BRG1 overexpression and IFNg stimulation
- Adenocarcinoma of breast CAL-120 cells with BRG1 knockout or treated with infigratinib
- Mixed lineage leukemia MV-4-11 cells treated with BRD4 shRNA knockdown and DOT1L inhibitor SGC0946
- Adrenal carcinoma SW13 cells; response to BRG1 overexpression and UV-C treatment
Most Relevant Literature
- SWI/SNF regulation of germinal center fate and lymphomagenesis.
- SMARCA4 vulnerability in H3K27M midline glioma: A silver bullet for a lethal disease.
- Metastatic thoracic SMARCA4-deficient undifferentiated tumour masquerading as an iris tumour.
- Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors.
- NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour: facts and controversies.
Most Relevant Clinical Trials
- A Study of PRT3789 in Participants With Select Advanced or Metastatic Solid Tumors With a SMARCA4 Mu…
- Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficien…
- Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
- Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory M…
- Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
